^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ScTIL

    i
    Other names: ScTIL
    Associations

    News

    Trials
    Company:
    Chineo Medical Technology
    Drug class:
    Immunomodulator
    Related drugs:
    Associations

    News

    Trials
    over2years
    A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors (clinicaltrials.gov)
    P1, N=48, Not yet recruiting, Chinese Academy of Medical Sciences
    New P1 trial
    |
    PD-1 (Programmed cell death 1)
    |
    ScTIL
    over2years
    Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies (clinicaltrials.gov)
    P2a, N=30, Not yet recruiting, Peking Union Medical College Hospital
    New P2a trial
    |
    CD19 (CD19 Molecule)
    |
    Loqtorzi (toripalimab-tpzi) • ScTIL